ANGO · Angiodynamics Inc
Market Cap
$619.99M
Shares
41.33M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| Investor Event Transcript | 2026-08-11 | 2026-02-28 | |
| 8-K | 2026-07-14 | — | |
| 10-K | 2026-07-14 | 2026-05-31 | |
| Investor Event Transcript | 2026-06-10 | 2025-11-30 | |
| 8-K | 2026-04-23 | — | |
| Investor Event Transcript | 2026-04-14 | 2025-11-30 | |
| 10-Q | 2026-04-02 | 2026-02-28 | |
| 8-K | 2026-04-02 | — | |
| 8-K | 2026-02-03 | 2026-01-30 | |
| 8-K | 2026-01-14 | — | |
| 10-Q | 2026-01-06 | 2025-11-30 | |
| 8-K | 2026-01-06 | — | |
| 8-K | 2025-11-12 | 2025-11-10 | |
| 8-K | 2025-10-02 | — | |
| 10-Q | 2025-10-02 | 2025-08-31 | |
| DEF 14A | 2025-09-25 | 2025-05-31 | |
| 10-K | 2025-07-18 | 2025-05-31 | |
| 8-K | 2025-07-15 | — | |
| 8-K | 2025-05-28 | — | |
| 8-K | 2025-04-02 | — | |
| 10-Q | 2025-04-02 | 2025-02-28 | |
| 8-K | 2025-04-02 | — | |
| 8-K | 2025-01-16 | — | |
| 10-Q | 2025-01-08 | 2024-11-30 | |
| 8-K | 2025-01-08 | — | |
| 8-K | 2025-01-08 | — | |
| 8-K | 2024-11-15 | 2024-11-12 | |
| 8-K | 2024-10-03 | — | |
| 10-Q | 2024-10-03 | 2024-08-31 | |
| DEF 14A | 2024-09-26 | 2024-05-31 | |
| 10-K | 2024-07-25 | 2024-05-31 | |
| 8-K | 2024-07-16 | — | |
| 8-K | 2024-07-16 | — | |
| 10-Q | 2024-04-09 | 2024-02-29 | |
| 8-K | 2024-04-04 | — | |
| 8-K | 2024-04-01 | 2024-03-31 | |
| 8-K | 2024-02-13 | 2024-02-08 | |
| 8-K | 2024-01-22 | 2024-01-16 | |
| 8-K | 2024-01-11 | — | |
| 10-Q | 2024-01-08 | 2023-11-30 | |
| 8-K | 2024-01-05 | 2023-12-29 | |
| 8-K | 2023-11-16 | 2023-11-14 | |
| 10-Q | 2023-10-05 | 2023-08-31 | |
| 8-K | 2023-10-04 | — | |
| DEF 14A | 2023-09-28 | 2023-05-31 | |
| 10-K | 2023-08-03 | 2023-05-31 | |
| 8-K | 2023-07-24 | 2023-07-19 | |
| 8-K | 2023-07-12 | — | |
| 8-K | 2023-06-14 | 2023-06-08 | |
| 8-K | 2023-06-08 | — |
Showing 1–50 of 108 filings
Key facts
CIK
1275187
CUSIP
03475V101
13F (30d)
128 filings
128 filers
Visit website
Investor relations